Published in Women's Health Weekly, June 17th, 2004
The research appeared in the June 1, 2004, issue of the Journal of Clinical Oncology.
Although survival rates for early-stage breast cancer patients have improved over the last 5 years, many women still die from the disease. In this new study, the Georgetown team found that women whose tumors retain Stat5, a protein biomarker, have a highly favorable prognosis and may be cured by surgery and local therapy alone instead of additional...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly